Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death and is
currently the main event leading to death in patients with cirrhosis. Evolving information …

Several therapeutic procedures have been proposed as bridging treatments for patients with
hepatocellular carcinoma (HCC) awaiting liver transplantation (LT). The most used …

Importance Expansion of donor acceptance criteria for liver transplant increased the risk for
early allograft failure (EAF), and although EAF prediction is pivotal to optimize transplant …

Background The ability to predict graft failure or primary nonfunction at liver transplant
decision time assists utilization of scarce resource of donor livers, while ensuring that …

Locoregional therapy (LRT) is being increasingly used for the management of
hepatocellular cancer (HCC) in patients listed for liver transplantation (LT). Although several …

Since Italian liver allocation policy was last revised (in 2012), relevant critical issues and
conceptual advances have emerged, calling for significant improvements. We report the …

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. The
treatment of HCC is complex and complicated by the severity of associated chronic liver …

Objective: To evaluate the use of elderly donors in liver transplantation (LT) and identify risk
factors associated with a worse outcome. Summary Background Data: Use of livers from …

Portal vein thrombosis (PVT) is a well-known and relatively common complication of liver
cirrhosis. In the past, PVT was considered as a contraindication for liver transplantation (LT) …

In 2010, 1770 lung transplant procedures were performed in the USA, yet 2469 new
candidates were added to the waiting list the same year. The shortage of suitable donor …